广州维力医疗器械股份有限公司 关于控股股东股份延期质押的公告

Core Viewpoint - The announcement details the share pledge situation of the company's controlling shareholder, Gao Bo Investment (Hong Kong) Co., Ltd., including the number of shares pledged and the extension of pledge periods. Group 1: Shareholding and Pledge Details - As of February 24, 2026, Gao Bo Investment holds 92,019,200 shares, accounting for 31.53% of the company's total share capital, with a total of 26 million shares pledged, representing 28.25% of its holdings and 8.91% of the total share capital [1] - The initial pledge of 20 million shares was made on February 26, 2019, with a pledge period ending on February 25, 2021. This was later adjusted to 26 million shares due to a capital increase on May 25, 2020 [2] - The pledge of 26 million shares was extended multiple times, with the latest extension on February 24, 2023, pushing the pledge period to February 25, 2024 [3] Group 2: Recent Developments - On February 24, 2025, the remaining 10 million shares were again pledged, extending the pledge period to February 25, 2026 [4] - Gao Bo Investment has assured that the pledge does not involve guarantees for major asset restructuring or performance compensation [4] - The company emphasizes that the share pledge will not lead to a change in actual control and that Gao Bo Investment has sufficient financial capability to manage risks, with no current risk of forced liquidation [5]